Literature DB >> 7496344

Microperimetry in patients with central serous retinopathy.

F Toonen1, A Remky, V Janssen, S Wolf, M Reim.   

Abstract

In patients with acute central serous retinopathy (CSR), evaluation of visual acuity alone may not represent visual function. In patients with acute CSR, visual function may be disturbed by localized scotomas, distortion, and waviness. For the assessment of localized light sensitivity and stability of fixation, patients with CSR were evaluated by fundus perimetry with a scanning laser ophthalmoscope (SLO 101, Rodenstock Instruments). In all, 21 patients with acute CSR and 19 healthy volunteers were included in the study. Diagnosis of CSR was established by ophthalmoscopy and digital video fluorescein angiography. All patients and volunteers underwent static suprathreshold perimetry with the SLO. Light sensitivity was quantified by presenting stimuli with different light intensities (intensity, 0-27.9 dB above background; size, Goldmann III; wavelength, 633 nm) using an automatic staircase strategy. Stimuli were presented with simultaneous real-time monitoring of the retina. Fixation stability was quantified by measuring the area encompassing 75% of all points of fixation. Light sensitivity was 18-20 dB in affected areas, whereas in healthy eyes and outside the affected area, values of 22-24 dB were obtained. Fixation stability was significantly decreased in the affected eye as compared with normal eyes (33 +/- 12 versus 21 +/- 4 min of arc; P < 0.01). Static perimetry with an SLO is a useful technique for the assessment of localized light sensitivity and fixation stability in patients with macular disease. This technique could provide helpful information in the management of CSR.

Entities:  

Mesh:

Year:  1995        PMID: 7496344

Source DB:  PubMed          Journal:  Ger J Ophthalmol        ISSN: 0941-2921


  7 in total

1.  Translocation of iris pigment epithelium in patients with exudative age-related macular degeneration: long-term results.

Authors:  Alexandra Lappas; Andreas M H Foerster; Andreas W A Weinberger; Silke Coburger; Norbert F Schrage; Bernd Kirchhof
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-08-06       Impact factor: 3.117

2.  [Central serous chorioretinopathy--retinal function and morphology: microperimetry and optical coherence tomography].

Authors:  C Springer; H E Völcker; K Rohrschneider
Journal:  Ophthalmologe       Date:  2006-09       Impact factor: 1.059

3.  Blue on yellow perimetry with scanning laser ophthalmoscopy in patients with age related macular disease.

Authors:  A Remky; A E Elsner
Journal:  Br J Ophthalmol       Date:  2005-04       Impact factor: 4.638

4.  Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level.

Authors:  W-M Chan; D S C Lam; T Y Y Lai; B S M Tam; D T L Liu; C K M Chan
Journal:  Br J Ophthalmol       Date:  2003-12       Impact factor: 4.638

5.  Macular sensitivity and fixation patterns in normal eyes and eyes with uveitis with and without macular edema.

Authors:  Yasir J Sepah; Elham Hatef; Elizabeth Colantuoni; Jianmin Wang; Mathew Shulman; Fatima Idrees Adhi; Abeer Akhtar; Mohamed Ibrahim; Afsheen Khwaja; Roomasa Channa; Raafay Sophie; Millena Bittencourt; Jangwon Heo; Diana V Do; Quan Dong Nguyen
Journal:  J Ophthalmic Inflamm Infect       Date:  2011-12-14

6.  A microperimeter that provides fixation pattern and retinal sensitivity measurement.

Authors:  Miki Sawa; Fumi Gomi; Ayako Toyoda; Yasushi Ikuno; Takashi Fujikado; Yasuo Tano
Journal:  Jpn J Ophthalmol       Date:  2006 Mar-Apr       Impact factor: 2.211

7.  Clinical application of optical coherence tomography in combination with functional diagnostics: advantages and limitations for diagnosis and assessment of therapy outcome in central serous chorioretinopathy.

Authors:  Joshua A Schliesser; Gary Gallimore; Nancy Kunjukunju; Nelson R Sabates; Peter Koulen; Felix N Sabates
Journal:  Clin Ophthalmol       Date:  2014-11-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.